Our providers are here to help you make progress that feels sustainable, not overwhelming, so you can take control of your health
Metabolism & Elimination The metabolic fate and degradation pathways of MOTS-c remain incompletely characterized, representing a significant gap in pharmacokinetic understanding: Rapid plasma clearance observed in preclinical models, though precise half-life not definitively established Likely degradation through peptidase activity, though specific enzymes not identified No accumulation detected in chronic administration studies (animal models) Active metabolites not characterized
But there there is still a significant concern particularly for obesity which again, I think doctor Frank said, you know, this is treated maybe as a a point in time condition as opposed to an ongoing chronic condition that needs to be treated, you know, across the patients lifetime that, you know, this initial, you know, very significant investment in these medications, you know, may be for naught
The implications extend beyond diabetes, with broad applications in oncology, neurodegenerative, and inflammatory diseases, potentially accelerating the development of new treatments
How much protein should I eat after stopping GLP-1